Literature DB >> 25024368

Use of transgenic parasites and host reporters to dissect events that promote interleukin-12 production during toxoplasmosis.

David A Christian1, Anita A Koshy2, Morgan A Reuter3, Michael R Betts3, John C Boothroyd4, Christopher A Hunter5.   

Abstract

The intracellular parasite Toxoplasma gondii has multiple strategies to alter host cell function, including the injection of rhoptry proteins into the cytosol of host cells as well as bystander populations, but the consequence of these events is unclear. Here, a reporter system using fluorescent parasite strains that inject Cre recombinase with their rhoptry proteins (Toxoplasma-Cre) was combined with Ai6 Cre reporter mice to identify cells that have been productively infected, that have been rhoptry injected but lack the parasite, or that have phagocytosed T. gondii. The ability to distinguish these host-parasite interactions was then utilized to dissect the events that lead to the production of interleukin-12 p40 (IL-12p40), which is required for resistance to T. gondii. In vivo, the use of invasion-competent or invasion-inhibited (phagocytosed) parasites with IL-12p40 (YET40) reporter mice revealed that dendritic cell (DC) and macrophage populations that phagocytose the parasite or are infected can express IL-12p40 but are not the major source, as larger numbers of uninfected cells secrete this cytokine. Similarly, the use of Toxoplasma-Cre parasite strains indicated that dendritic cells and inflammatory monocytes untouched by the parasite and not cells injected by the parasite are the primary source of IL-12p40. These results imply that a soluble host or parasite factor is responsible for the bulk of IL-12p40 production in vivo, rather than cellular interactions with T. gondii that result in infection, infection and clearance, injection of rhoptry proteins, or phagocytosis of the parasite.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25024368      PMCID: PMC4187868          DOI: 10.1128/IAI.01643-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

1.  Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanism of entry.

Authors:  D G Mordue; L D Sibley
Journal:  J Immunol       Date:  1997-11-01       Impact factor: 5.422

2.  In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.

Authors:  T M Scharton-Kersten; T A Wynn; E Y Denkers; S Bala; E Grunvald; S Hieny; R T Gazzinelli; A Sher
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

3.  NK cell-derived interferon-γ orchestrates cellular dynamics and the differentiation of monocytes into dendritic cells at the site of infection.

Authors:  Romina S Goldszmid; Pat Caspar; Aymeric Rivollier; Sandy White; Amiran Dzutsev; Sara Hieny; Brian Kelsall; Giorgio Trinchieri; Alan Sher
Journal:  Immunity       Date:  2012-06-29       Impact factor: 31.745

Review 4.  Epidemiology of and diagnostic strategies for toxoplasmosis.

Authors:  Florence Robert-Gangneux; Marie-Laure Dardé
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  Studies on the role of interleukin-12 in acute murine toxoplasmosis.

Authors:  C A Hunter; E Candolfi; C Subauste; V Van Cleave; J S Remington
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

6.  CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites.

Authors:  Mona Mashayekhi; Michelle M Sandau; Ildiko R Dunay; Eva M Frickel; Asis Khan; Romina S Goldszmid; Alan Sher; Hidde L Ploegh; Theresa L Murphy; L David Sibley; Kenneth M Murphy
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

7.  Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control.

Authors:  Barbara A Butcher; Barbara A Fox; Leah M Rommereim; Sung Guk Kim; Kirk J Maurer; Felix Yarovinsky; De'Broski R Herbert; David J Bzik; Eric Y Denkers
Journal:  PLoS Pathog       Date:  2011-09-08       Impact factor: 6.823

8.  Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction.

Authors:  T Scharton-Kersten; C Contursi; A Masumi; A Sher; K Ozato
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

Review 9.  Interferon-inducible effector mechanisms in cell-autonomous immunity.

Authors:  John D MacMicking
Journal:  Nat Rev Immunol       Date:  2012-04-25       Impact factor: 53.106

10.  The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells.

Authors:  X Ma; J M Chow; G Gri; G Carra; F Gerosa; S F Wolf; R Dzialo; G Trinchieri
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more
  20 in total

1.  IL-1R signaling enables bystander cells to overcome bacterial blockade of host protein synthesis.

Authors:  Alan M Copenhaver; Cierra N Casson; Hieu T Nguyen; Matthew M Duda; Sunny Shin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-01       Impact factor: 11.205

Review 2.  Imaging flow cytometry analysis of intracellular pathogens.

Authors:  Viraga Haridas; Shahin Ranjbar; Ivan A Vorobjev; Anne E Goldfeld; Natasha S Barteneva
Journal:  Methods       Date:  2016-09-15       Impact factor: 3.608

3.  Caspase-8 promotes c-Rel-dependent inflammatory cytokine expression and resistance against Toxoplasma gondii.

Authors:  Alexandra A DeLaney; Corbett T Berry; David A Christian; Andrew Hart; Elisabet Bjanes; Meghan A Wynosky-Dolfi; Xinyuan Li; Bart Tummers; Irina A Udalova; Youhai H Chen; Uri Hershberg; Bruce D Freedman; Christopher A Hunter; Igor E Brodsky
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-30       Impact factor: 11.205

Review 4.  Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis.

Authors:  Hany M Elsheikha; Christina M Marra; Xing-Quan Zhu
Journal:  Clin Microbiol Rev       Date:  2020-11-25       Impact factor: 26.132

5.  Flt3 Ligand Is Essential for Survival and Protective Immune Responses during Toxoplasmosis.

Authors:  Christopher D Dupont; Gretchen Harms Pritchard; Shinya Hidano; David A Christian; Sagie Wagage; Gaia Muallem; Elia D Tait Wojno; Christopher A Hunter
Journal:  J Immunol       Date:  2015-09-18       Impact factor: 5.422

6.  Impact of Toxoplasma gondii on Dendritic Cell Subset Function in the Intestinal Mucosa.

Authors:  Sara B Cohen; Eric Y Denkers
Journal:  J Immunol       Date:  2015-08-17       Impact factor: 5.422

7.  The IL-12 Response of Primary Human Dendritic Cells and Monocytes to Toxoplasma gondii Is Stimulated by Phagocytosis of Live Parasites Rather Than Host Cell Invasion.

Authors:  Kevin W Tosh; Lara Mittereder; Sandra Bonne-Annee; Sara Hieny; Thomas B Nutman; Steven M Singer; Alan Sher; Dragana Jankovic
Journal:  J Immunol       Date:  2015-11-23       Impact factor: 5.422

Review 8.  The role of IL-12 in stimulating NK cells against Toxoplasma gondii infection: a mini-review.

Authors:  Sepideh Mahmoudzadeh; Hojjatollah Nozad Charoudeh; Cláudia Silva Marques; Saeed Bahadory; Ehsan Ahmadpour
Journal:  Parasitol Res       Date:  2021-06-10       Impact factor: 2.289

9.  Neurons are the Primary Target Cell for the Brain-Tropic Intracellular Parasite Toxoplasma gondii.

Authors:  Carla M Cabral; Shraddha Tuladhar; Hans K Dietrich; Elizabeth Nguyen; Wes R MacDonald; Tapasya Trivedi; Asha Devineni; Anita A Koshy
Journal:  PLoS Pathog       Date:  2016-02-19       Impact factor: 6.823

Review 10.  Deploying FLAREs to Visualize Functional Outcomes of Host-Pathogen Encounters.

Authors:  Lena J Heung; Anupam Jhingran; Tobias M Hohl
Journal:  PLoS Pathog       Date:  2015-07-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.